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Traumatic brain injury (TBI) is often thought to be a disease of young men. However, women 
comprise approximately 40% of the TBI population. In the era of personalized medicine, it is 
critical that we examine questions related to gender and outcomes after TBI, not only from the 
perspective of natural recovery, but also from the response to treatment. Many pharmacological 
agents are administered post-TBI, and given biological differences in males and females, the 
beneficial or deleterious effects of these pharmacological agents may or may not be equivalent 
between the sexes.  
 Haloperidol (HAL) is often prescribed in the clinic to manage TBI-induced agitation and 
aggression. HAL has consistently been shown to hinder functional recovery in male rats after 
experimental TBI, but whether these effects extend to females is not well established. Therefore, 
the objective of this study is to conduct an experiment examining differences between male and 
female rats in the response to HAL. To further understand this clinically relevant issue male and 
female rats received either a SHAM injury or a controlled cortical impact and were treated with 
either a vehicle solution (1mL/kg) or HAL (0.5mg/kg) starting 24 hours after injury and continuing 
once a day for 19 consecutive days. In regards to motor function TBI females performed better 
than TBI males. Furthermore, TBI females that received HAL performed better than TBI male that 
received HAL. With respect to cognitive function, which consisted of acquisition of spatial 
learning and memory retention, HAL was found to be deleterious to spatial learning acquisition in 
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the male TBI group, but did not appear to affect retention, as measured in the probe trial. In 
conclusion, the results of my experiment demonstrate that chronic administration of the 
antipsychotic drug HAL produces differences in recovery between males and females, as 
illustrated through tests of motor and cognitive function. Specifically, males performed worse than 
females, which replicate previous work from our laboratory. This finding is clinically significant 
because it can allow medical professionals to individualize medicine and to determine the most 
efficient treatment plan.  
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1.0  TRAUMATIC BRAIN INJURY AND ITS CONSEQUENCES 
In the United States alone approximately 1.7 million people suffer a TBI annually. Moreover, TBI 
is a contributing factor to nearly one-third of all injury related deaths (Center for Disease Control, 
2010). These alarmingly high rates cost the United States over $60 billion in indirect and direct 
medical costs (Center for Disease Control, 2010). There are numerous ways in which individuals 
can obtain a TBI. According to the Center for Disease Control falls made up over 40% of all TBIs 
between 2006 and 2010, followed by unknown causes, and then motor vehicle accidents (Center 
for Disease Control, 2004). The risk of different causes of TBI may vary based on many factors, 
including age and gender (Center for Disease Control, 2004). 
 Once a TBI has occurred, mechanisms of change in the brain can be categorized into 
primary, secondary, and repair-regeneration stages (Marion, 1999). The primary injury stage is the 
result of the mechanical disruption of the brain that occurs as a direct response to trauma of the 
head. Primary injuries include penetrating damage, cortical contusions, damage to the vascular 
supply, and axonal shearing. Secondary injury results from the neurochemical and physiological 
effects that are initiated due to the primary trauma (Marion, 1999). The results of a secondary 
injury can include, but are not limited to, vascular changes, hypotension, cerebral edema, 
excitotoxicity and increased intracranial pressure. The repair-regeneration, is the third stage, and 
is the least understood stage of TBI, which is why current research needs to focus on this stage. 
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There is little time for intervention in the primary and secondary stages of injury making the repair-
regeneration stage the most logical to study.  
There are multiple functional and behavioral consequences of TBI, including changes in 
sensation, cognition, motor function, and emotion. An overview of these changes is provided in 
the following paragraphs.  
 
1.1 SENSATION 
The manner in which an individual with a TBI senses the environment can be severely 
altered. Impairments within the primary senses, such as somatosensation, vision, hearing, 
vestibular function, smell and taste are all potential consequences of TBI (Bach & David, 2006). 
In addition, individual with TBI may also experience altered sensation. Tingling and painful 
sensations are common. Scotoma and diplopia may cause blind spots in the visual field, blindness, 
and poor visiomotor integration. A consistent ringing in the ear, tinnitus, may add to a person’s 
inability to concentrate. Vertigo and balance problems are also common after TBI. Hypogleusia 
alters the way a person perceives taste after TBI. Agnosia, the inability to discriminate one 
sensation from another is another possible deficit after TBI; this may cause a person to have 
difficulties recognizing objects (Bach & David, 2006). These TBI induced alterations in sensation 
make it difficult for a person to successfully reintegrate into society.  
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1.2 COGNITIVE FUNCTION 
Following a TBI a plethora of cognitive deficits may be present depending on the severity 
and location of the injury. Attention and memory problems are a common complaint after a TBI, 
potentially affecting short-term and long-term memory (DiPaola et al., 2014). Often a person may 
have trouble concentrating after a TBI and may be easily distracted, and have difficulty staying on 
task or sitting for long periods of time. When a person’s attention and memory both acutely and in 
the long term are affected by a TBI, understanding and processing information may become 
difficult. Attention and memory problems are not only an inconvenience but can lead to dangerous 
situations such as leaving a stove unattended or forgetting to take medication.  
Besides attention and memory deficits, a person with TBI may endure may other kinds of 
cognitive deficits. The ability to processes and form language is a highly complex process that is 
often affected by TBI not only due to cognitive deficits but motor deficits can impact one’s ability 
to communicate (Center for Disease Control, 2004). Furthermore, executive functioning such as 
working memory, reasoning, task flexibility and problem solving can be severely impacted (Hamm 
et al., 1992; Ratcliff et al., 2007). Sequencing abilities may be disrupted as a result of a TBI, which 
makes activities such as following directions or participating in multistep tasks extremely 
challenging (Liossi et al., 2009). 
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1.3 MOTOR FUNCTION 
While cognitive dysfunction can be the result of injuries throughout the brain, motor 
dysfunction is associated with focal injuries to selected regions of the brain (Fujimoto et al., 2004). 
Spastic weakness, defined by resistance to passive stretch in the muscles and lack of voluntary 
motor control, can cause difficulties when performing even basic motor tasks. As a result, persons 
with spasticity may have difficulty with even the simplest activities of daily living. A person with 
a TBI may also have difficulties with balance and coordination (Murphy & Carmine, 2012). 
Slowness in movement and responses, bradykinesia, is often a common complaint after injury 
(Murphy & Carmine, 2012). Speech problems due to motor dysfunction such as dysarthria and 
oral apraxia may make communication post-injury difficult. These are only some of the most 
common motor dysfunctions after TBI. However it is possible to have a wide range of other 
symptoms depending on individual circumstances.   
 
1.4 EMOTIONAL/BEHAVIORAL FUNCTION 
After TBI, a person’s behavior and emotional well-being may be altered due to 
neurochemical changes and situational factors. Agitation is often one of the earliest changes in 
behavior, particularly among individuals with moderate to severe TBI. Treating agitation is 
challenging because most of the pharmacological agents have sedative effects hindering the 
patient’s ability to participate in a rehabilitation program and some agents have been known to 
cause long-term cognitive deficits, even after discontinuing the treatment (Phelps et al., 2014). 
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However, long after the acute period of recovery, changes in behavior and emotional well- being 
may persist. Emotional dysregulation may make it difficult for a person to deal with stressors of 
everyday life. A person with emotional dysregulation may have unchecked emotional responses 
or exhibit inappropriate emotions in situations (Paradiso et al., 1999). Depression is a very 
common outcome of a TBI due to changes in brain physiology and the situational circumstances 
(Fedio et al., 2014). Depression makes it difficult for a person to participate in therapy hindering 
the rehabilitation process. Likewise, anxiety is a common consequence, which can make the 
individual difficult to treat in the clinical setting. Aggression is a frequent product of a TBI, which 
can make the person anxious, and, in some circumstances, dangerous to treat or even dangerous to 
themselves.  
In summary, there are multiple functional and behavioral consequences of TBI. The 
particular pattern of changes may vary based on the cause of the injury, the location and severity 
of the injury, and the specific mechanisms of change in the brain associated with these factors. 
Additional factors may also influence functional and behavioral changes. Among these factors, 
gender is of particular interest.  
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2.0  RATIONALE FOR EXAMINING GENDER AS A FACTOR INFLUENCING TBI 
OUTCOMES 
There are a number of reasons why gender is of particular interest when examining TBI 
outcomes. Although TBI is generally more common among men, women comprise 40% of 
individuals with TBI (Center for Disease Control, 2010). Furthermore, meta-analyses and 
systematic reviews suggest that gender may be critical factor influencing functional outcomes after 
TBI (Farace & Wayne, 2000). Differences in outcomes may be due to differences in causes of 
injury, psychological and social factors, and physiological factors.  
In general, men are at a greater risk of acquiring a TBI, particularly during late adolescence 
and young adulthood (up to the age of 30) (Center for Disease Control, 2010). During these high-
risk years, often christened the “testosterone years,” men are at a higher risk of motor vehicle 
accidents and interpersonal violence. Specifically men are six times more likely to receive a TBI 
due to a gunshot wound and about three times more likely to suffer a TBI as a result of a motor 
vehicle accident (Marion, 1999). However, among older adults (ages 65 and above), women are at 
higher risk for TBI (typically due to falls) (Bruns & Hauser, 2003). The higher risk for women in 
this age group could be explained by the fact that, in general, women have a longer life expectancy, 
and therefore are more prevalent in this age group.  
There are many psychological and social differences between males and females that have 
the potential to impact functional outcomes after TBI. Depression is a disorder that causes a 
depressed mood and loss of interest in activities that normally bring pleasure for at least two weeks. 
Depression is nearly twice as prevalent in females as compared to males (Ven de Velde, Piet 
&Leveque, 2010). Depression has been linked with poor outcomes after TBI because it can 
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interfere with a person’s ability to participate in activities of daily living and instrumental activities 
of daily living. Therefore, women may be more likely to experience poor outcomes (Richardson 
et al., 2014).  
Societal expectations may also influence outcomes for males and females after TBI. For 
example, in current American society, there is a higher expectation for males to be employed 
outside of the home than females. If this pressure is present prior to injury it is likely going to be 
present after injury. Thus, males may be more likely to return to work following a TBI thus 
achieving a better outcome, according to selected measures, than females. This difference in 
outcomes may not be based purely on differences in neurological recovery, but also due to 
differences in the societal pressure to be employed outside of the home.  
Another example of differences in societal expectations between males and females relates 
to expectations for the role of the caregiver. Approximately 78% of caregivers of individuals with 
TBI are females (Sander et al., 2007). This could be explained not only by the higher incidence of 
TBI in males leaving females to be the primary caregiver but also by societal expectations for 
females to assume roles as caregivers. This, added to the fact that females with TBI tend to be 
older, and outlive their partners, leads to the implication that females are less likely to return home 
and instead remain in institutions (thus an unfavorable outcome). These are just a few of the 
psychological and societal differences that can influence functional outcomes after TBI however.  
Males and females are not only psychologically and socially different, they are also 
physiologically different. Among the more obvious differences between males and females are 
testosterone and estrogen levels. Due to hormonal differences, male and female brains do not 
respond to neurotransmitters and drugs the same way (McEwen, 1991). Females are more likely 
to express higher levels of Interleukin-1, which is pro-inflammatory after stress, such as trauma 
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(Arakawa et al., 2014). Conversely, estrogen has been shown to have neuroprotective properties 
by the activation of cell survival mechanisms (Chakrabarti et al., 2014; Djebaili et al., 2004; Roof 
& Hall, 2000). These differences could influence not only severity of secondary injuries but also 
the path of recovery for both sexes.  
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3.0  GENDER AND ITS INFLUENCE ON FUNTCIONAL OUTCOMES AFTER TBI 
To better understand differences in functional outcomes between men and women, I 
conducted a search of the recent literature examining differences in functional outcomes based on 
gender. Specifically, a PubMed search for data-based research articles was initiated using the 
search terms “traumatic brain injury”, “gender” and “outcomes”. Articles were excluded if they: 
focused on pediatrics, did not examine gender as an independent variable, and those published 
before 1998 (when the last systematic review examining gender and its influences on functional 
outcomes after TBI was published). The bibliographies of the included articles were searched for 
additional relevant articles that may have not been found in the PubMed search. This process was 
continued until saturation was achieved. From the selected articles, information related to the 
setting (acute, subacute or chronic), experimental comparison, and male and female outcomes was 
extracted. A summary of the included studies and extracted information is presented in Figure 1.  
The results of the review suggest that females fared better on the Glasgow Coma Scale 
(Slewa-Younan et al., 2004) and the Glasgow Outcome Scale (Brazinova et al., 2010). The 
Glasgow Coma Scale is a basic scale that measures responsiveness acutely while the Glasgow 
Outcome Scale measures disability chronically. These two studies suggest that females have less 
severe injuries initially and continue to have lower levels of disability chronically.  
On the other hand, males fared better on outcome measures such as the Functional 
Independence Measure (FIM) (Graham et al., 2010 & Lecours et al., 2012), as well as discharge 
location and levels of scheduled home health care (Graham et al.,2010). The FIM is an assessment 
of basic self-care and functional mobility, and is strongly influenced by motor function. Given that 
males had higher FIM scores at discharge, it is not surprising that they were more likely to be 
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discharged home (rather than to an institution) and had less scheduled home health care. Discharge 
disposition and home health follow-up might also be influenced by the fact that males are more 
likely to have a primary caregiver, as previously discussed. Females could possibly be more likely 
to go to assisted living or have higher levels of home health care simply because they were the 
primary caregiver of their household so there is no one to take care of them post-injury due to 
practical reasons.  
The results of this review suggest that there are no differences in post-injury complication 
such as pneumonia, acute respiratory distress syndrome, and bacteremia. Males and females also 
exhibited comparable levels of agitation post injury (Kayden et al., 2004; Magnotti et al., 2008). 
It is important to note that the Agitated Behavior Scale was used to measure agitation, and it has 
poor inter-rater reliability. Also, the behaviors on the scale are highly reflective of severe agitation 
such as: violence, explosive anger and repetitive behaviors. These indices may be comparable 
between males and females, whereas other indices of agitation such as shortness of temper may be 
different between males and females.  
The findings are mixed with respect to differences in mortality, cognitive and affective 
outcomes, and employment outcomes after TBI. The three articles within this review that 
examined mortality differences reported three different conclusions. Davis et al., (2006) suggested 
that females were less susceptible to mortality than males; however, the groups were extremely 
unequal, with over seven thousand more male participants in the study. Ottochain et al., (2009) 
suggested that males fared better, but their sample contained female participants who were 
significantly older and more severely injured than their male counterparts. Magnotti et al., (2008) 
found that males and females were equivalent in terms of mortality; however, once again the 
comparison groups were highly unequal with nearly ten thousand more male participants than 
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female participants; furthermore, male participants had significantly lower Glasgow Coma scale 
scores upon admission on average. Thus, age and severity may be stronger predictors of mortality 
after TBI than gender. However, it remains unclear.  
Furthermore, studies that examined cognitive and affective outcomes after injury also 
presented mixed findings. Liossi et al., (2009) examined cognitive and affective outcomes after 
TBI and found that females were significantly more impaired in verbal and visual memory and 
these deficits increased in severity with increasing age. Females also had higher levels of anxiety 
and depression. The correlation between age and degree of cognitive impairment in females 
suggest that estrogen, which decreases with age, is connected to these measures. Unfortunately, 
this study contained no control participants. Given that females in general are more prone to 
anxiety in general, it is unclear whether these differences can be attributed to the TBI. According 
to Ratcliff et al., (2007) females after TBI perform worse than males in tests of visual analytic 
skills, which is reflective of the general population and not limited to the TBI population alone. 
This study also found that males perform worse in tests of language, which is incongruent with the 
findings of Liossi et al., (2009). These two studies do a good job describing the affective and 
cognitive differences after brain injury. However, little is spoken about differences prior to injury 
making it unclear if the differences after injury are due to preexisting variances or the results of 
injury.  
Differences in employment and work capacity after TBI are also difficult to interpret. Pre-
existing gender differences and societal expectations with respect to employment and work 
capacity confound post-TBI outcomes. Bounds et al., (2003) found significant differences in 
successful employment after TBI in their sample which contained people with a lower than average 
socioeconomic status (SES). Groswasser et al., (1998) looked at work capacity rather than actual 
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successful employment, which eliminated some of the societal biases. All participants were at an 
inpatient rehabilitation center and the method for measuring work capacity was not clearly stated 
in the study. However, the study suggests that females fared better than their male counterparts in 
this specific study. The disagreement between actual employment and work capacity suggests that 
societal pressures may be a factor in this measure.  
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Figure 3-1: Scoping Review 
 
 
Year Outcome 
measure 
Setting  Comparison Populations  Findings Who Fared 
Better?  
Groswasser 1998 Work Capacity Acute/ 
Subacute  
Females: n=34 & Males: n=79,Age 5-65years, 
Mechanism of injury not reported  
Females had significantly 
better functional outcome 
(p˂0.016) 
Females 
Kraus  2000 Mortality  Acute/ 
Subacute  
Females: 16-29 yrs (n=49), 30-49yrs 
(n=47),≥50 yrs(n=47),  Blunt injury (n=129), 
Penetrating Injury (n=14)        Males: 16-29 yrs 
(n=285), 30-49 yrs (n=240), ≥50 yrs (n=127), 
Blunt Injury (n=556), Penetrating Injury (n=96) 
Females had 1.28 times 
higher mortality than 
males 
Males 
Bounds 2003 Successful 
employment 
through DVR  
Chronic Females (n=23) and Males (n=55), 18-57 yrs  4.3% of females 
successfully employed as 
compared to 23.6% of 
males 
Males 
Slewa-
Younan 
2004 GCS,PTA and 
multiple 
outcome 
measures  
Acute Females (n=54) and Males(n=54)  in high 
speed MVA, 16-37 years of age 
Females had lesser 
severity of injury and 
length of PTA 
Females 
Kadyan 2004 Agitation (ABS) Acute  Females(n=38) and Males (n=120) between 
18-86 yrs. Mechanism of injury: MVA (n=99), 
Violent assault n=24), Falls (n=18), Other 
(n=17) 
Females are equally likely 
to exhibit signs of 
agitation as males in peak 
intensity and average 
intensity 
Equal 
Davis 2006 Mortality  Acute  Females (15-49 years n=1881, ≥50 n=1297) 
and Males (15-49 years n=7891, ≥50 n=2368). 
Mechanism of injury not reported.  
Post-menopausal females 
had greater survival rate 
was significantly better 
than males of the same 
age.  
Females 
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 Corrigan  2007 Employment 1 
year after TBI 
Chronic Females (n=957) and Males (n=2487) 18-65 
years of age.  
Females were more likely 
to decrease work hours or 
stop working. Except in 
the oldest age group (55-
64yrs) where males were 
more likely to stop 
working. Female 
employment outcomes 
got better as the age 
increased.  
Mixed 
Ratcliff 2007 1 year after 
injury- 
attention/workin
g memory, visual 
memory, verbal 
memory, 
language, visual 
analytic skilled, 
problem solving 
and motor 
functioning  
Chronic  Females (n=100) and Males (n=225) 16-45 yrs. 
Mechanism of injury was not reported.  
 Females performed 
better in tests of 
attention/working 
memory and language 
however did worse in 
tests of visual analytic 
skills.  
Mixed 
Magnotti 2008 Ventilator 
associated 
pneumonia, 
ARDS, 
bacteremia, 
ventilator days, 
ICU days, length 
of hospital stay 
and mortality  
Acute  Females (≤40yrs n=6,476, >50 yrs n=3,007) 
and Males (≤40yrs n=14,934, >50 yrs n=5,194) 
who suffered a blunt impact injury.  
Females had equal 
survival Gender alone 
offers no survival 
advantage.  
Equal 
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Liossi 2009 Cognitive and 
Affective 
outcomes 
Subacute
/Chronic  
Females (n=162) and Males (n=358) between 
20-60 yrs. Mechanism of injury: MVA (70%), 
Falls (15%), Assault (8%), Pedestrian Injury 
(7%)  
Females were significantly 
more impaired in verbal 
and visual memory and 
cognitive deficits 
increased with age in 
Females (role of estrogen 
on hippocampus?).   
Females had higher levels 
of anxiety and depression 
post TBI  
Males 
Ottochain 2009 Mortality  Acute Females (˂14y n=44, 14-44 n=123, 45-54 n=55, 
≥55 n=184) and Males (˂14y n=27, 14-44 
n=172, 45-54 n=67, ≥55 n=147). Mechanism of 
injury not reported.  
Females over the age of 
55 (post menopause?) 
had worse outcomes 
Males 
Brazinova 2010 GCS score 
greater than or 
equal to 4 
Chronic Females (n=29) and Males (n=71) ≥65 with 
initial GCS ≤8. Mechanism of injury not clearly 
stated.  
Females had more 
favorable outcomes.  
Females 
Graham 2010 Rehab length of 
stay, discharge 
FIM motor and 
cognitive, 
discharge setting 
and scheduled 
home health  
Subacute  Females (n=8,650) and Males ≥65 (n=18,413). 
Mechanism of injury not clearly reported.  
Females had lower length 
of stay, lower cognitive 
and motor FIM and 
greater scheduled home 
healthcare  
Mixed 
Brown 2012 Discharge 
location 
Acute Females (n=1,899, MVA n=222, , Other 
n=1677) and Males (n=1,581, MVA n=242, , 
Other n=133) ≥65yrs.  
Females 1.3 times more 
likely to be sent to a care 
facility instead of home 
Males 
Lecours 2012 13 motor factors 
of FIM 
Chronic  Females (n=63) and Males (n=73) ≥ 55 years, 
mechanism of injury not reported.  
Males fared better Males 
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One can conclude from this review that it is reasonable to consider gender when examining 
TBI outcomes and the effects of intervention after TBI. Nonetheless, methodological issues limit 
conclusions that can be drawn from this review. Unfortunately, studies in the review varied greatly 
in recruitment and assessment methods, limiting the conclusions to be drawn from the review. 
Sampling methods yielded highly variable samples with respect to cause, location and severity of 
injury, let alone respective numbers of male and female participants. Furthermore, many of the 
assessment methods have questionable validity. Finally, variability in pharmacological and 
rehabilitation interventions was not measured or reported, raising questions about the consistency 
of treatment exposure that TBI participants had across studies. It is impossible for clinical 
researchers to control for factors such as age and gender.  
Some of the methodological issues that are apparent in clinical studies may be addressed 
through pre-clinical studies. Laboratory experiments, using rat models, allow for the scientists to 
control factors that might influence outcomes, and isolate the effects of gender. For example, 
variability due to genetic make-up, pre-injury and post-injury environment, and cause, location, 
and severity of injury can be better controlled in rat models. Furthermore, pre- injury function and 
post-injury pharmacotherapy and rehabilitation can also be delivered in a more controlled fashion 
than what can be done in clinical studies. Thus, laboratory experiments with rat models offer 
advantages for isolating the effects of gender on TBI outcomes.  
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4.0  DIFFERENTIAL RESPONSE TO PHARMACOLOGICAL AGENTS: 
IMPLICATIONS BASED ON A SINGLE EXPERIMENT  
Given the reasons to suspect gender differences in outcomes, and the mixed results in the 
literature, we designed a single controlled experiment examining gender differences in response 
to a pharmacological agent often used to treat agitation after TBI. For the purposes of this 
experiment, we chose to focus on a treatment for agitation is a common symptom after TBI, and 
our review suggested that males and females experience comparable levels of agitation after TBI 
(Kadyan et al., 2004). We chose to focus on haloperidol (HAL) because it is frequently used to 
treat agitation after TBI, and the differences in HAL response attributed to gender are unclear. 
Previous studies have examined the effects of HAL in male rats alone but the results have not been 
compared to those of female rats (Kline et al., 2008). Our intent was to clarify the impact of HAL 
as a preface to future studies examining alternative treatments.  
HAL is highly effective in producing sedative effects to treat TBI-induced agitation and 
aggression. However, HAL is known to produce Tardive dyskinesia in ten to twenty percent of 
patients receiving this treatment long term (Horn & Zasler, 1996). It is important to note the 
possible motor deficits caused by HAL. With the neurological burden that HAL can place on 
patients with a TBI it is important to weigh the risks with the benefits. The risk to benefit ratio 
may however be different depending on the gender of the patient receiving this pharmacological 
treatment.  
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4.1 MECHANISM OF ACTION 
HAL is a high potency typical antipsychotic drug that acts by antagonizing D2 receptors. 
Due to the D2 receptor blockade, extrapyramidal symptoms are very common. These pyramidal 
symptoms include: tremor, spasticity, akinesia and bradykinesia. Furthermore, HAL has effects on 
5-HT1 and 2, D1 and α1 and α2 receptors however this activity is low. Also, HAL has minimal 
affinity to H1 and 5-HT1A receptors (Karl et al., 2006).   
 
4.2 GENDER AND MEDICATION RESPONSE 
In general, female patients are more likely to report side effects due to a medication. 
However, male patients may be more sensitive. Morag, Oved and Gurwitz (2012) compared 
immortalized human lymphoblastoid cell lines (LCLs) from unrelated females and males to 
examine sensitivity to common drugs, and demonstrated that males were more responsive and 
sensitive, to most medications. This finding suggests that there may be differences between how 
females and males respond to HAL but limited research in the differences in sensitivity to HAL 
between the two genders has been completed.  
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4.3 HALOPERIDOL AND BRAIN INJURY 
HAL is commonly used after TBI to alleviate symptoms of agitation and aggression. Based 
on a survey by Fugate et al., (1997) of rehabilitation physicians with expertise in TBI, HAL was 
listed as physicians’ drug of choice for the treatment of agitation 11% of the time. However, 25% 
of physicians reported using HAL when other treatments were ineffective. Furthermore, non-
experts were significantly more likely to use HAL than experts (those who spent 70% of their time 
treating TBI or published at least two evaluation papers focusing on pharmacologic intervention 
after TBI in the last five years)(Fugate et al., 1997).  
Even though HAL is frequently prescribed, it has been associated with poor cognitive and 
motor outcomes in experimental models of TBI. In a study by Kline et al., (2008) the effects of 
HAL on behavioral outcome were examined in male rats after a controlled cortical impact (CCI). 
The study and others found that HAL impaired the acquisition of spatial learning in the Morris 
water maze (Hoffman et al., 2008; Kline et a., 2008). This preclinical study suggests that HAL is 
detrimental to functional recovery. Unpublished studies from this same laboratory show that HAL 
reduces the efficacy of environmental enrichment, which has been shown to robustly improve 
function recovery after CCI (Monaco et al., 2013; Kline et al., 2008; Phelps et al., 2014).  
Furthermore, although HAL is highly effective as a sedative agent it has the potential to 
produce serious side effects in patients (such as TBI patients) including neuroleptic malignant 
syndrome (NMS) (Bellamy et al., 2009). Symptoms of NMS include rigidity, fever, autonomic 
instability and cognitive changes that are thought to be result of the dopamine receptor blockade 
caused by HAL (Wilkinson et al., 1999). Interestingly, NMS is more common in males as 
compared to females suggesting that males are more sensitive to the D2 receptor antagonistic 
activity of HAL.  
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In order to further explore the clinically relevant issue of gender differences in functional 
outcome after the chronic administration of HAL after TBI a single experiment was conducted. 
The goal of this study was to determine if gender differences in neurologic functional outcomes 
are different due to the effects of HAL. By using a rat model more variables could be held constant 
than in a clinical setting allowing any difference between the groups to be associated with gender 
and HAL.  
4.4 METHODS 
4.4.1 SUBJECTS 
Thirty-two normal adult cycling female and thirty male Sprague-Dawley rats were subject 
to the experimental protocol. Rats were placed into the following conditions illustrated in figure 
4-1.  
Figure 4-1: Experimental Groups 
 Male Female 
 CCI SHAM CCI SHAM 
VEH n=10 n=5 n=6 n=6 
HAL n=10 n=5 n=10 n=10 
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4.4.2 HOUSING CONDITIONS 
Ten days prior to surgery rats arrived to the laboratory to become acclimated to conditions. 
All rats were housed in the same colony room, which was kept at a constant temperature (21±1°C). 
A light cycle was also kept constant for all rats with light being on between 7:00am-7:00pm. Food 
and water was available continuously throughout the experiment. Rats were housed two per cage. 
Female and male rats were kept separate throughout the experiment.  
 
 
4.4.3 ESTROUS CYCLE MONITORING 
Prior to surgery and the first day of Morris water maze testing, all female rats were 
evaluated for estrous stage. Following vaginal smear epithelial cells were examined by a light 
microscope. Rats were categorized as: proestrous, estrous, or diestrous based on highly 
distinguishable cellular characteristics (Monaco et al., 2013).  
Figure 4-2: Estrous Stages 
Differential interference contract micrographs of primary stages of the rat estrous cycle. (A) 
Typical cell pattern for diestrous. Smears include large numbers of leukocytes with scattered 
nucleated epithelial and cornified cells. (B) Typical cell pattern for proestrous. Smears include 
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primary epithelial cells with large nuclei. (C) Typical cell pattern for estrous. Smears include 
primarily cornified epithelial cells. (Wagner et al., 2004). 
 
4.4.4 SURGERY 
All rats received either a controlled cortical impact (CCI) or a SHAM injury (Dixon et al., 
1991; Kline et al., 2008). Surgical anesthesia was induced using 4% isoflurane then maintained at 
2% isoflurane. Rats were ventilated mechanically and maintained at a temperature of 37±0.5°C by 
use of a heating pad. Before the procedure started, each rat was secured using a stereotaxic frame. 
All rats received a midline scalp incision and the fascia was moved to expose the skull. A 
craniotomy was made over the right hemisphere of the brain by use of a hand held trephine; the 
bone flap was then removed.  
The impacting rod (6mm, flat) was carefully positioned, centered in the craniotomy until 
it lightly touched the Dura mater. The impact tip was advanced 2.8mm further to produce a brain 
injury of moderate severity (2.8 mm tissue deformation at 4 m/sec). Immediately after impact 
anesthesia was discontinued. Sham rats were subjected to the same procedure, excluding impact.  
 
 
4.4.5 ACUTE NEUROLOGICAL TESTING 
Following the discontinuation of anesthesia acute neurological testing was administered. 
Hindlimb withdraw reflex was tested bilaterally by pinching the rat’s paw with forceps every 5 
seconds. The time it took for the withdraw reflex to return was recorded. The return of the righting 
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reflex was monitored by placing the rat supine and recording the time it took to return to a prone 
position (Monaco et al., 2013). These acute measures are sensitive indicators of injury severity and 
anesthetic effects.  
 
4.4.6 DRUG ADMINISTRATION  
HAL and VEH were made fresh daily by dissolving in 1:1 dimethyl sulfoxide and saline, 
which also served as the vehicle. Drug administration started 24 hours after surgery once daily 
following behavioral testing at a dose of 0.5mg/kg HAL or 1mL/kg vehicle. Drugs were 
administered intraperitoneally. The dose of HAL was chosen due to the concentrations being 
comparable to that used in the clinical setting (Zou et al., 2010).  
 
 
4.4.7 MOTOR ASSESMENT: BEAM TASKS 
Motor function was assessed using the beam-balance and beam walk tasks (Kline et al., 
2008, Phelps et al., 2014, Manaco et al., 2013). Prior to injury, all rats received equal training on 
motor tasks to ensure an equal baseline. For the beam-balance task, the rat was placed on a beam 
that is 90 cm above ground level and 1.5 cm wide and the time is recorded that the rat balances for 
a maximum for 60 s. Prior to injury, all rats were trained to be able to balance for 60 seconds.  
The beam walk task used the negative reinforcement of pink noise and bright light to 
encourage the rat traverse across a raised narrow beam of 100 centimeters. At the end of the beam 
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there was a darkened goal box, once the rat reached the box the negative stimuli were discontinued. 
Distance traversed and times to traverse were both recorded. A rating scale of 0- 5 was used to rate 
distance traversed with, 0 being failure to move from the starting box and a 5 being entrance to 
goal box. A maximum of 60 seconds was allotted for each trial of this task.  
Motor function was assessed prior to surgery and post-operatively for five days and at the 
same time daily. For all motor testing the average of three trials was subjected to statistical 
analysis.  
 
4.4.8 COGNITIVE ASSESSMENT: MORRIS WATER MAZE  
The well-established Morris Water Maze was used to measure acquisition of spatial 
learning and memory (Morris, 1984). The maze consists of a blue plastic pool (160cm diameter, 
60cm high) that was filled with tap water to 28cm. A clear platform made of Plexiglas was placed 
in the southwest quadrant of the pool 26 cm from the wall of the pool and 2 cm below the water 
level. Water temperature was held constant throughout testing at 26±1°C. Around the room which 
held the pool are constant visual cues. The position of the platform was held constant throughout 
all trials and rats. Spatial learning acquisition started on day 14 post- operative and continued for 
five consecutive days.  
Cognitive testing was conducted at the same time each day. Each rat underwent four trials 
with a maximum allotted time of 120 seconds with a four-minute rest period between trials during 
which the rat was placed in a heated incubator. The rat was placed in the pool from one of four 
starting positions (North, East, South, and West) in a randomized order. If the rat failed to locate 
the platform in the 120 seconds allotted time it was manually guided to the platform. Once the rat 
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found the platform it was given a 30 s learning period on the platform. The average of the four 
daily trials were averaged and subjected to statistical analysis.  
On post-operative day 19, the platform was raised 2 centimeters out of the water and 
outlined with white tape therefore, making the platform visible to the rat. Other than the raised 
visible platform all other water maze procedures were kept constant for this trial. These trials were 
used for a control procedure to ensure that the rats’ visual acuity was intact. The state of the rats’ 
visual acuity was important to check to ensure that rat was able to see the visual cues around the 
room.  
 
4.4.9 PROBE TRAIL: MEMORY RETANTION 
On day 19 prior to the visual trials, a single probe trial was conducted to assess memory 
retention. For this trial the platform was removed from the pool and the percent time the rat spent 
in the target quadrant was recorded. It was expected that a rat that learned where the platform was 
located would spend significantly more time in the target quadrant. The rat was placed in the pool 
and allowed to freely explore for 30 seconds. Swim speeds were also gathered during this trial. 
Swim speeds were collected to ensure that there were no differences in swim speeds between the 
groups because this would impact the amount of time it took the rat to find the platform.  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4.5 STATISTICAL ANALYSIS  
All statistical analyses were performed using Statview by observers who were blinded to 
the experimental conditions. The behavioral data were analyzed with repeated-measures analysis 
of variance (ANOVA). If the ANOVA revealed statically significant results the data were then 
further analyzed with the Fisher’s PLSD post-hoc test to reveal specific differences between the 
experimental groups. The data were considered to be significant when the p value was ≤ 0.05.   
 
4.6 RESULTS 
Rats were excluded from statistical analysis if they were unsuccessful in finding the 
platform during the visible platform trial because this suggested that their visual acuity was not 
intact. There were no differences in any of the SHAM injury conditions between the drug 
conditions therefore; their data were pooled together for simplicity.  
 
4.6.1 ACUTE NEUROLOGICAL FUNCTION 
Significant differences in the left hind limb withdraw reflex were detected between TBI+ 
VEH females and the TBI +HAL males (p=0.0027), between both TBI + HAL (p=0.0010), and 
between the TBI and SHAM injury groups (p <0.0001). Significant differences occurred in right 
hind limb withdraw between the TBI + VEH females and TBI + HAL males (p=0.0015). No other 
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significant differences existed between the TBI groups. No significant differences were observed 
between any of the TBI groups in the time to exhibit the righting reflex (p <0.0001), which is a 
robust measure of injury severity.  
 
4.6.2 MOTOR FUNCTION: BEAM-BALANCE 
There were no pre-surgical differences between any of the rats, as they were all able to 
balance on the beam for the maximum allotted time of 60 seconds. Following CCI the ANOVA 
revealed significant Group [F5.62 = 14.093, p <0.0001] and Day [F5,310 = 45.197, p < 0.0001] 
differences, as well as a significant Group × Day interaction [F25,310 = 7.430, p <0.0001]. Post- 
hoc analysis revealed that the TBI+ VEH female group recovered significantly faster than the TBI 
+ HAL male group (p <0.0001, Fig 1.). In addition the TBI + HAL females recovered significantly 
faster than the TBI + VEH males (p<0.0001). Lastly, the TBI + VEH male group receiving vehicle 
recovered significantly faster than their counterparts receiving TBI+ HAL (p=0.002).  
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Figure 4-3: Beam Balance 
 
Mean (±S.E.) beam balance ability prior to, and after, TBI or SHAM injury. The * indicates 
SHAM p<0.001 vs. all TBI groups regardless of treatment. The # symbol indicates that the female 
TBI + VEH group was significantly different than TBI + HAL males (p<0.001).  The  ^symbol 
indicates that the TBI + VEH males were significantly different than the TBI+ HAL females 
(p<0.001) and TBI + HAL males (p=0.0020).  
 
 
4.6.3 MOTOR FUNCTION: BEAM- WALK (TIME) 
No pre-surgical differences in the ability to traverse the beam were revealed among the 
groups. Following CCI the ANOVA revealed significant Group [F5,62 = 145.040, p <0.0001] and 
Day [F5,310 = 195.137 p < 0.0001] differences, as well as a significant Group × Day interaction 
[F25,310 = 21.966 p <0.0001]. Post-hoc analysis revealed that the only significant differences 
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among TBI groups existed between the TBI + HAL females and the TBI + HAL males (p= 0.0003). 
Females recovered significantly faster than their male counterparts receiving the same treatment 
condition.  
Figure 4-4: Beam Walk Time 
 
Mean (±S.E.) beam-walking ability (time) prior to, and after TBI or SHAM injury. * All 
SHAM injury groups were significantly different than all TBI groups (p<0.001). ^  The TBI + HAL 
female group was significantly different than the TBI + HAL male group (p=0.003).  
 
 
4.6.4 MOTOR FUNCTION: BEAM-WALK (DISTANCE) 
No pre-surgical differences were revealed. All rats were capable of traversing the entire 
length of the beam. Following CCI the ANOVA revealed significant Group  [F5,62 = 91.509,p 
<0.0001] and Day [F5,310 = 144.066, p < 0.0001] differences, as well as a significant Group × 
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Day interaction [F25,310 = 16.076, p <0.0001]. Post-hoc analysis revealed three significant 
differences observed among the TBI groups. The TBI + VEH female group recovered significantly 
faster than the TBI + HAL male group (p=0.0004). In addition the TBI + HAL female group 
recovered faster than the TBI + VEH male (p=0.0030) group and the TBI + HAL male group 
(p<0.0001).  
Figure 4-5: Beam Walk Distance 
 
Mean (±S.E.) beam-walking ability (distance) prior to, and after TBI or SHAM injury. * 
All SHAM injury groups were significantly different than all TBI groups (p<0.001). $ TBI + VEH 
females preformed significantly different than the TBI + HAL males (p=0.0004). ^ TBI + HAL 
females traversed the beam significantly different better than both male TBI groups: VEH 
(p=0.0030) and HAL (p<0.0001).  
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4.6.5 COGNIIVE FUNCTION: ACQUISITION OF SPATIAL LEARNING (TIME TO 
PLATFORM) 
The ANOVA revealed significant Group [F5, 62 = 22.465, p <0.0001] and Day  [F4,248= 
40.929, p < 0.0001] differences. Post-hoc analysis of the Morris water maze data revealed that the 
TBI + VEH male group was able to locate the platform significantly faster than the TBI + HAL 
male group (p=0.0008). No other significant differences were observed among the TBI groups. 
There were no significant differences in any groups during the visible trials (p<0.0001).  
Figure 4-6 Morris Water Maze 
 
Mean (±S.E.) to find platform (sec). *SHAM groups preformed significantly better than 
all TBI groups (p<0.0001). # The only other statistically significant difference is the male TBI + 
VEH preformed significantly better than the male TBI+ HAL group (p=0.0008). Day 19 shows 
that with a visible platform all animals were able to find the platform in fewer than 120 sec.  
Time after injury (days)
14 15 16 17 18 19
Ti
m
e 
to
 p
la
tfo
rm
 (s
ec
)
0
20
40
60
80
100
120
TBI + VEH (Female) 
TBI + HAL (Female) 
SHAM (Female) *
TBI + VEH (Male) #
TBI + HAL (Male) 
SHAM (Male) *
 31 
 4.6.6 COGNTIVE FUNCTION: AQUISTITION OF SPATIAL LEARNING (TIME TO 
PLATFORM ON DAY 18) 
Following CCI the ANOVA revealed significant Group [F5, 62 = 13.053, p <0.0001] 
differences. Post-hoc analysis of time to platform on day 18 revealed the female TBI + VEH group 
was significantly better than either group receiving HAL regardless of gender. Additionally, the 
female TBI + VEH group was significantly better on day 18 than the male TBI + VEH group. 
Furthermore, the male TBI + VEH group performed better than the male TBI +HAL group, which 
replicated previous studies from my laboratory.  
Figure 4-7: Morris Water Maze Day 18 
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Mean (±S.E.) time to find platform on day 18 post injury. SHAM injury groups performed 
significantly better than all TBI groups (p<0.0001). * Female TBI + VEH group was significantly 
different than female TBI + HAL (p=0.0367) and male TBI + VEH (p=0.0450). ^ Male TBI + 
VEH performed significantly different than female TBI + HAL (p=0.0114) and male TBI + HAL 
(p=0.0130).  
 
4.6.7 COGNTIVE FUNCTION: PROBE TRIAL (MEMORY RETENTION) 
Following CCI the ANOVA revealed no significant Group [F5,62 = 1.134, p = 0.3522] 
differences. Post-hoc analysis showed the only difference the existed among the groups during the 
probe trial was between the female TBI+VEH group and the SHAM female group (p=0.0455).  
Figure 4-8: Probe Trial 
 
Mean (±S.E.) percent time in the target quadrant during the probe trial. * Female TBI+VEH 
group and the SHAM female group (p=0.0455).  
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4.6.8 COGNTIVE FUNCTION: SWIM SPEED 
Following CCI the ANOVA revealed no significant Group [F5,62 = 2.008, p =0.0898] 
differences.  
Figure 4-9: Swim Speed 
 
Mean (±S.E.) swim speed in cm/sec on day 19 post injury. No significant difference 
between any of the groups.  
 
4.7 DISCUSSION  
Previous studies have shown that the antipsychotics drugs (APDs) HAL and risperidone 
prevent recovery of cognitive function in male rats after TBI (Kline et al., 2008; Hoffman et al., 
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2008; Phelps et al., 2014). Unfortunately, there has been very little research on the drug’s effects 
on recovery in females, leading to a lack of understanding of whether these deleterious effects are 
similar between males and females. The goal of this experiment was to determine if HAL produces 
the same detrimental effects in females as it does in males. The results suggest that females do 
respond differently to HAL after TBI, in most measures HAL does not impede recovery to the 
same degree as it does in males.  
Specifically regarding motor function, there were no pre-injury differences between male 
and female rats. However after TBI, the SHAM injury groups performed better than the TBI 
groups. Additionally, in general, female TBI rats performed better than male TBI rats, but the 
effects of HAL varied. Furthermore, female TBI + HAL performed better than male TBI +HAL. 
These findings suggests that with respect to motor function, TBI may not impair females as 
severely as males, and that HAL may not have the same deleterious effects on female’s with TBI. 
Support for males rats faring worse after TBI + HAL treatment comes from a study by Feeney et 
al. (1982) who showed that HAL produced negative motor recovery outcomes in males after TBI. 
This preclinical finding also supports clinical data that human males are more sensitive to HAL 
than females (Oved & Gurwitz, 2012).  
With respect to cognitive function, which consisted of acquisition of spatial learning and 
memory retention, HAL was found to be deleterious to spatial learning acquisition in the male TBI 
group, but did not appear to affect retention, as measured in the probe trial. The swim speed 
measure obtained during the probe trial may be influenced by both motor and cognitive 
performance.  
It has been demonstrated that TBI produces significant disruptions of normal dopaminergic 
neurotransmitter physiology (Massucci et al, 2004; McIntosh et al, 1994). As previously indicted, 
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HAL demonstrates a high affinity for dopamine D2 receptors, where it acts as an antagonist. 
Additionally, D2 receptor agonists, such as bromocriptine and amantadine, produce more 
favorable outcomes after TBI in males (Dixon et al, 1999; Kline et al., 2004; Phelps et al., 2014). 
This could lead one to believe that there may be differences between genders in D2 receptor affinity 
to HAL and/or gender differences in the metabolism of HAL.  
Hormones are a variable that differ between male and females and hence it is reasonable 
to believe that testosterone and estrogen may play a part in the differences observed when HAL as 
a treatment after TBI. Previously McEwen (1991) found that hormonal differences cause the brain 
to respond differently to neurotransmitters and pharmacological treatments. Additionally, estrogen 
has been found to have neuroprotective properties because of its role in activation of cell survival 
mechanism (Chakrabarti et al., 2014). The neuroprotective properties of estrogen may lessen the 
deleterious effects of HAL after TBI.  
This study serves as a stepping-stone for future studies to explore gender differences after 
TBI. Another strategy that may lessen the negative effects of HAL is environmental enrichment 
(EE) has been shown to provide robust neurological benefits after TBI in both males and females 
(Bondi et al., 2014; Cheng et al., 2012; de Witt et al., 2011; Monaco et al., 2013). Unpublished 
studies from our laboratory have demonstrated that EE lessens the appallingly negative outcomes 
associated with HAL. Future studies should examine females exposed to environmental 
enrichment and HAL in combination and compare the results to that of males.  
Another interesting approach that could be taken is to study estrogen therapy in 
combination with HAL in male rats after TBI. By studying this combination of treatments 
experimenters would be able to speculate further if hormones are responsible for the differences 
between males and females after TBI when HAL is used as a treatment.  
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These findings are important because of the potential implications for rehabilitation. This 
study suggests that HAL inhibits motor recovery more significantly in males, than in females. This 
could diminish the benefits of occupational and physical therapy for males who sustain TBI. 
Furthermore, this study suggests that HAL causes significant cognitive deficits after TBI, which 
could lead to further decline in a patient’s cognitive status after TBI. For example, if D2 receptor 
antagonists are used more therapy may be required for the patient to reach the same milestones as 
if they were not being treated with a D2 receptor antagonist.  
Despite the data showing that antipsychotic drugs such as HAL is detrimental to the 
recovery process, such agents are still required for patient management. Fortunately, our laboratory 
has shown that antipsychotic drugs, which have different mechanisms of action, do not impair 
recovery after TBI and in fact may actually provide some cognitive benefit. Unpublished data from 
our laboratory suggests that aripiprazole does not negatively impact motor function and actually 
positively impacted spatial learning acquisition. The different outcomes may be attributed to the 
mechanism of action in that aripiprazole is a D2 agonist and a 5HT1A partial agonist. Studies from 
our lab have shown that drugs with this mechanism of action may be beneficial to functional 
recovery after TBI (Kline et al., 2004; Phelps et al., 2014). Moreover, the sedative drug lorazepam 
also does not appear to produce negative effects on outcome after TBI. Data from our laboratory 
suggests that lorazepam does not negatively impact motor or cognitive functional outcomes after 
TBI and therefore should be considered a valid alternative to HAL (unpublished).  
Taken together, the two studies just described suggest that patients may be treated 
efficiently for TBI-induced agitation and aggression without restricting their ability to recover 
spontaneously after TBI. Whether these drugs produce the same effects in females is not known, 
but is the focus of future studies in our laboratory.  
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5.0  CONCLUSION  
In conclusion, the literature suggests, that although the findings are yet unclear, there are 
reasons to suspect that males and females may respond differently to treatment after TBI. The 
results of my experiment support this premise, demonstrating that chronic administration of the 
antipsychotic drug HAL produces differences in recovery between males and females, as 
illustrated through tests of motor and cognitive function. Specifically, males performed worse than 
females, which replicate previous work from our laboratory. The novelty of this experiment is that 
the data show that females were not as impaired. These findings may help rehabilitation 
practitioners design more effective and personalized interventions to meet the needs of all TBI 
patients exhibiting agitation and aggression. In addition, these findings provide support for 
additional controlled experiments examining differences in treatment response between males and 
females who have sustained TBI.  
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